Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-α and IL-6 inhibitors with antioxidant activity

被引:28
作者
Bandgar, Babasaheb P. [1 ,2 ]
Patil, Sachin A. [2 ]
Totre, Jalinder V. [2 ]
Korbad, Balaji L. [2 ]
Gacche, Rajesh N. [3 ]
Hote, Baliram S. [2 ]
Jalde, Shivkumar S. [2 ]
Chavan, Hemant V. [1 ]
机构
[1] Solapur Univ, Sch Chem Sci, Organ Chem Res Lab, Solapur 413255, India
[2] Swami Ramanand Teerth Marathwada Univ, Sch Chem Sci, Organ Chem Res Lab, Nanded 431606, India
[3] Swami Ramanand Teerth Marathwada Univ, Sch Life Sci, Nanded 431606, India
关键词
Nitrogen-containing benzophenone; Anti-inflammatory; TNF-alpha; IL-6; Antioxidant activity; TUMOR-NECROSIS-FACTOR; MAP KINASE INHIBITORS; INTERLEUKIN-1; SELECTIVITY; MECHANISMS; CYTOKINES; MEDIATORS; EFFICACY; ASSAY;
D O I
10.1016/j.bmcl.2010.02.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of nitrogen-containing benzophenone analogues were synthesized by Mannich reaction and evaluated for the inhibition of pro-inflammatory cytokines, TNF-alpha and IL-6. DPPH (1,1-diphenyl-2-picryl hydrazine) radical scavenging activity and its kinetics were studied to determine the antioxidant potential of the test samples. All the synthesized compounds exhibited promising activity against IL-6 in a range of 81-89%, 09-42% at 10 and 1 mu M, respectively, concentration. Exceptionally, the compound 20e was observed to be an effective inhibitor of TNF-alpha (54%) and IL-6 (97%), (47%) at 10 and 1 mu M concentrations with minimum toxicity (22%) against CCK-8 cells. With few exceptions, all other compounds were found to be excellent inhibitors of IL-6 and moderate to excellent inhibitors of TNF-a, however the toxicity profiles of these compounds need to be ameliorated in further optimization studies. Amongst the tested compounds, 16a, 17g, 18f, 18g, 19g and 20e were found to possess significant antioxidant activity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2292 / 2296
页数:5
相关论文
共 32 条
[1]  
AHLUWALIA VK, 2005, INTERMEDIATES ORGANI, P192
[2]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[3]  
Barnes PJ, 1998, PHARMACOL REV, V50, P515
[4]   In vitro antioxidant activity of red grape skins [J].
Bartolomé, B ;
Nuñez, V ;
Monagas, M ;
Gómez-Cordovés, C .
EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2004, 218 (02) :173-177
[5]   A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[6]  
DAYER JM, 1984, SPRINGER SEMIN IMMUN, V7, P387
[7]   DEVELOPMENT OF A PROPIDIUM IODIDE FLUORESCENCE ASSAY FOR PROLIFERATION AND CYTOTOXICITY ASSAYS [J].
DENGLER, WA ;
SCHULTE, J ;
BERGER, DP ;
MERTELSMANN, R ;
FIEBIG, HH .
ANTI-CANCER DRUGS, 1995, 6 (04) :522-532
[8]   INFLAMMATORY CYTOKINES - INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR AS EFFECTOR MOLECULES IN AUTOIMMUNE-DISEASES [J].
DINARELLO, CA .
CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (06) :941-948
[9]  
HWANG CD, 1993, J IMMUNOL, V151, P5631
[10]  
Jiri J., 1991, CSECH CS, V271, P185